Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 May;26(3):731-732.
doi: 10.1007/s10741-020-09950-y.

Soluble CD146-an underreported novel biomarker of congestion: a comment on a review concerning congestion assessment and evaluation in acute heart failure

Affiliations
Review

Soluble CD146-an underreported novel biomarker of congestion: a comment on a review concerning congestion assessment and evaluation in acute heart failure

Justas Simonavičius et al. Heart Fail Rev. 2021 May.

Abstract

In spite of high prevalence, congestion remains a poorly understood phenomenon in heart failure pathophysiology. Its negative impact on outcome has been widely recognised. Still, data from various registries reveal the failure of the contemporary treatment strategies to overcome congestion. This shortcoming is closely related to the fact that there are no universe means for congestion assessment and grading, making it a difficult process to recognise. CD146 is a novel blood biomarker of congestion that has been shown to reflect intravascular fluid accumulation in a number of experimental and clinical studies. This observation deserves special attention, given the huge gap of knowledge about decongestive strategies in acute and chronic heart failure. Randomised clinical trials testing the effect of CD146-guided management intervention are urgently needed to estimate its value in heart failure care.

Keywords: CD146; Congestion; Fluid accumulation; Heart failure; Loop diuretic; Overhydration.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Palazzuoli A, Evangelista I, Nuti R (2020) Congestion occurrence and evaluation in acute heart failure scenario: time to reconsider different pathways of volume overload. Heart Fail Rev 25:119–131. https://doi.org/10.1007/s10741-019-09868-0 - DOI - PubMed
    1. Leroyer AS, Blin MG, Bachelier R et al (2019) CD146 (cluster of differentiation 146): an adhesion molecule involved in vessel homeostasis. Arterioscler Thromb Vasc Biol. https://doi.org/10.1161/atvbaha.119.312653
    1. Arrigo M, Truong QA, Onat D, Szymonifka J, Gayat E, Tolppanen H, Sadoune M, Demmer RT, Wong KY, Launay JM, Samuel JL, Cohen-Solal A, Januzzi JL Jr, Singh JP, Colombo PC, Mebazaa A (2017) Soluble CD146 is a novel marker of systemic congestion in heart failure patients: an experimental mechanistic and transcardiac clinical study. Clin Chem 63:386–393. https://doi.org/10.1373/clinchem.2016.260471 - DOI - PubMed
    1. Gayat E, Caillard A, Laribi S, Mueller C, Sadoune M, Seronde MF, Maisel A, Bartunek J, Vanderheyden M, Desutter J, Dendale P, Thomas G, Tavares M, Cohen-Solal A, Samuel JL, Mebazaa A (2015) Soluble CD146, a new endothelial biomarker of acutely decompensated heart failure. Int J Cardiol 199:241–247. https://doi.org/10.1016/j.ijcard.2015.07.039 - DOI - PubMed
    1. Van Aelst LNL, Arrigo M, Placido R et al (2017) Acutely decompensated heart failure with preserved and reduced ejection fraction present with comparable haemodynamic congestion. Eur J Heart Fail. https://doi.org/10.1002/ejhf.1050

LinkOut - more resources